Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury

Kidney International

Volumn 69, Issue 2, 2006, Pages 288-297

  Itoh, Y ^a   Yano, T ^a   Sendo, T ^a   Sueyasu, M ^a   Hirano, K ^b   Kanaide, H ^b   Oishi, R ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Akt; Apoptosis; Bcl 2; de novo ceramide synthesis; Radiocontrast medium; Renal tubular cells

Indexed keywords

2 (2 METHOXY 4 NITROPHENYL) 3 (4 NITROPHENYL) 5 (2,4 DISULFOPHENYL) 2H TETRAZOLIUM MONOSODIUM; ANTIBODY; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE INHIBITOR; CERAMIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOSERINE; FUMONISIN B1; IMIPRAMINE; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOMEPROL; IOMERON 400; IOPAMIDOL; IOTROLAN; IOVERSOL; MESSENGER RNA; NONIONIC CONTRAST MEDIUM; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; SPHINGOMYELIN; TETRAZOLIUM; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG; VISIPAQUE 320;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DAMAGE; CELL LABELING; CELL VIABILITY; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IN VIVO STUDY; INCUBATION TIME; KIDNEY DISEASE; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; LIPID DEGRADATION; LIPOGENESIS; MALE; MOUSE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE;

ACETYLGLUCOSAMINE; ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CERAMIDES; CONTRAST MEDIA; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FUMONISINS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY TUBULES; MICE; MITOCHONDRIA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SWINE; TRIIODOBENZOIC ACIDS;

EID: 33644641640     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000057     Document Type: Article

References (45)

1. Gruberg L, Mintz GS, Mehran R et al. Prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-1548.
2. Dangas G, Iakovou I, Nikolsky E et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005; 95: 13-19.
3. Liss P, Nygren A, Erikson U, Ulfendahl HR. Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 1998; 53: 698-702.
4. Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity. Kidney Int 2003; 64: 128-139.
5. Cox CD, Tsikouris JP. Preventing contrast nephropathy: what is the best strategy? A review of the literature. J Clin Pharmacol 2004; 44: 327-337.
6. Tepel M, van der Giet M, Schwarzfeld C et al. Prevention of radiographic contrast medium-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184.
7. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 2004; 65: 1366-1374.
8. 1 cells by activating A kinase/PI3 kinase. Kidney Int 2003; 64: 2052-2063.
9. 1 cells injury. Kidney Int 2004; 65: 1654-1663.
10. Yano T, Itoh Y, Kubota T et al. A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic AMP response element binding protein. Am J Pathol 2005; 166: 1333-1342.
11. 473. J Biol Chem 2000; 275: 13330-13335.
12. Stoica BA, Movsesyan VA, Lea IV PM, Faden AI. Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3β, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol Cell Neurosci 2003; 22: 365-382.
13. Iwata M, Herrington J, Zager RA. Sphingosine: a mediator of acute renal tubular injury and subsequent cytoresistance. Proc Natl Acad Sci USA 1995; 92: 8970-8974.
14. 1 cells. Kidney Int 1998; 54: 399-406.
15. Wang E, Norred WP, Bacon CW et al. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem 1991; 266: 14486-14490.
16. Holleran WM, Williams ML, Gao WN, Elias PM. Serine-palmitoyl transferase activity in cultured human keratinocytes. J Lipid Res 1990; 31: 1655-1661.
17. Luberto C, Hannun YA. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine- specific phospholipase C? J Biol Chem 1998; 273: 14550-14559.
18. Albouz S, Vanier MT, Hauw JJ et al. Effect of tricyclic antidepressants on sphingomyelinase and other sphingolipid hydrolases in C6 cultured glioma cells. Neurosci Lett 1983; 36: 311-315.
19. Meuillet EJ, Mahadevan D, Vankayalapati H et al. Specific inhibition of the Akt, pleckstrin homology domain by D-3-deoxy-phosphatidyl-myoinositol analogues. Mol Cancer Ther 2003; 2: 389-399.
20. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997; 3: 614-620.
21. Bourbouze R, Baumann FC, Bonvalet JP, Farman N. Distribution of N-acetyl-β-D-glucosaminidase isoenzymes along the rabbit nephron. Kidney Int 1984; 25: 636-642.
22. Itoh Y, Yano T, Sendo T, Oishi R. Critical review: clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 2005; 97: 473-488.
23. Robertson JD, Orrenius S. Role of mitochondria in toxic cell death. Toxicology 2002; 181-182: 491-496.
24. Kandel ES, Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999; 253: 210-229.
25. Goswami R, Dawson SA, Dawson G. Multiple polyphosphoinositide pathways regulate apoptotic signalling in a dorsal root ganglion derived cell line. J Neurosci Res 2000; 59: 136-144.
26. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999; 13: 2905-2927.
27. Pugazhenthi S, Nesterova A, Sable C et al. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 2000; 275: 10761-10766.
28. Pugazhenthi S, Miller E, Sable C et al. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. J Biol Chem 1999; 274: 27529-27535.
29. Powell DJ, Hajduch E, Kular G, Hundal HS. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol 2003; 23: 7794-7808.
30. 2 induce caspase-3-independent degradation of Akt/protein kinase B. J Biol Chem 2002; 277: 42943-44952.
31. Liu B, Andrieu-Abadie N, Levade T et al. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 1998; 273: 11313-11320.
32. Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest Radiol 2002; 37: 428-434.
33. Aspelin P, Aubry P, Fransson SG et al. Nephrotoxicity in high-risk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-499.
34. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188: 171-178.
35. Deray G, Dubois M, Martinez F et al. Renal effects of radiocontrast agents in rats: a new model of acute renal failure. Am J Nephrol 1990; 10: 507-513.
36. 1. J Comp Pathol 1997; 117: 371-381.
37. 1 renal epithelial cells via a sphinganine- and calmodulin-dependent pathway. Toxicol Appl Pharmacol 2001; 176: 118-126.
38. 1 cells. Toxicol Appl Pharmacol 1993; 114: 9-15.
39. Seefelder W, Humpf HU, Schwerdt G et al. Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites. Toxicol Appl Pharmacol 2003; 192: 146-153.
40. Dugyala RR, Sharma RP, Tsunoda M, Riley RT. Tumor necrosis factor-alpha as a contributor in fumonisin B1 toxicity. J Pharmacol Exp Trier 1998; 285: 317-324.
41. 1: a mycotoxin produced by Fusarium moniliforme (F. verticillioides). Cancer Detect Prev 2002; 26: 1-9.
42. Kubota T, Fujisaki K, Itoh Y et al. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Biochem Pharmacol 2004; 67: 2175-2186.
43. Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 1991; 30: 4480-4486.
44. Gupta AK, McKenna WG, Weber CN et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res 2002; 8: 885-889.
45. Inglefield JR, Mundy WR, Meacham CA, Shafer TJ. Identification of calcium-dependent and -independent signaling pathways involved in polychlorinated biphenyl-induced cyclic AMP-responsive element-binding protein phosphorylation in developing cortical neurons. Neuroscience 2002; 115: 559-573.